Literature DB >> 20175043

Recurrence risk of a delivery before 34 weeks of pregnancy due to an early onset hypertensive disorder: a systematic review.

Josje Langenveld1, Sofie Jansen, Joris van der Post, Hans Wolf, Ben Willem Mol, Wessel Ganzevoort.   

Abstract

Early onset hypertensive disorders of pregnancy are associated with adverse maternal and neonatal outcome. The risk of recurrence influences parents' choices on subsequent pregnancies and the counseling obstetrician, but evidence so far has been limited. We performed the first systematic review on the risk of recurrence of hypertensive disorders that had caused delivery <34 weeks. We searched Medline, Embase, and the Cochrane Library for articles published until September 2009 that report on pregnancy outcome after an earlier pregnancy complicated by early hypertension, preeclampsia, or hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome, which resulted in a delivery before 34 weeks. Recurrence rates of premature deliveries due to hypertensive disorders were calculated for each study separately. Pooled data were calculated. The search retrieved 36 relevant articles, of which 11 fulfilled the inclusion criteria. These 11 studies reported on 2377 patients (range 18 to 1754 patients per study), who had 2461 deliveries. Seven studies were included for further calculation. The pooled risk of a delivery before 34 weeks due to recurrence of hypertension, preeclampsia, or HELLP was 7.8% (95% confidence interval 6.7 to 9.0%). Opposed to some previous studies, the overall recurrence rate is generally low. The pooled recurrence risk of an early onset hypertensive disorder is approximately 8%. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20175043     DOI: 10.1055/s-0030-1248944

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  4 in total

1.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

2.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

3.  Annual body mass index gain and risk of hypertensive disorders of pregnancy in a subsequent pregnancy.

Authors:  Sho Tano; Tomomi Kotani; Takafumi Ushida; Masato Yoshihara; Kenji Imai; Tomoko Nakano-Kobayashi; Yoshinori Moriyama; Yukako Iitani; Fumie Kinoshita; Shigeru Yoshida; Mamoru Yamashita; Yasuyuki Kishigami; Hidenori Oguchi; Hiroaki Kajiyama
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

4.  Interaction of body mass index and hemoglobin concentration on blood pressure among pregnant women in Guangxi, China.

Authors:  Qiuan Zhong; Jiangyan Xu; Yingquan Long; Yingying Deng; Jinlan Hu; Xiaofei Li; Xiaoqiang Qiu
Journal:  BMC Public Health       Date:  2014-05-20       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.